The US has a herd immunity math problem, with a COVID-19 vaccine not yet approved for children under 16 and a third of adults saying they likely won't get it.
The US has a herd immunity math problem, with a COVID-19 vaccine not yet approved for children under 16 and a third of adults saying they likely won't get it.